(Q44282743)

English

Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

Terese L Katzenstein

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Røge BT

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nielsen HL

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Gerstoft J

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

38-47

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Interference between D30N and L90M in selection and development of protease inhibitor-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Impact of drug resistance mutations on virologic response to salvage therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00133.X

21 January 2018

Identifiers

10.1046/J.1468-1293.2003.00133.X

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

release_pvpgwthidraunl7n3gs4gphs2m

1 reference

https://api.fatcat.wiki/v0/release/pvpgwthidraunl7n3gs4gphs2m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44282743&oldid=2109122576"